| 6/24/2021 |
ESTRADIOL tablet [REMEDYREPACK INC.] |
National Institutes of Health |
... Get Label RSS Feed - View NDC Code(s)NEW! Updated June 23, 2021 If you are a consumer or patient please visit this version. Rx only ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There ... |
| 6/23/2021 |
ESTRADIOL tablet [Mylan Pharmaceuticals Inc.] |
National Institutes of Health |
... Resources] Updated August 15, 2018 If you are a consumer or patient please visit this version. ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There ... |
| 4/17/2021 |
Highlights: To date, no adverse cardiac events re |
wapakdailynews.com |
Highlights:To date, no adverse cardiac events related to SARS-CoV-2 infection have been observed among more than 3,000 collegiate athletes during short-term clinical surveillance . Findings suggest safe return-to-play without cardiac testing for asymptomatic or mildly symptomatic athletes. Embargoed until 12:00 p.m. CDT / 1:00 p.m. EDT April 17, 2021( 17, 2021 - DALLAS - While the lasting impact of COVID-19 on hospitalized patients in the general population ... |
| 4/17/2021 |
The Ridgway Record |
ridgwayrecord.com |
Highlights:To date, no adverse cardiac events related to SARS-CoV-2 infection have been observed among more than 3,000 collegiate athletes during short-term clinical surveillance . Findings suggest safe return-to-play without cardiac testing for asymptomatic or mildly symptomatic athletes. Embargoed until 12:00 p.m. CDT / 1:00 p.m. EDT April 17, 2021( NewMediaWire ) - April 17, 2021 - DALLAS - While the lasting impact of COVID-19 on hospitalized patients in the ... |
| 4/7/2021 |
VigiLanz Launches Intelligent Event Reporting Suite, Expands #1 Rated Clinical Surveillance Platform Impacting Patient Safety, Risk, Compliance, and Patient Relations |
PR Newswire |
MINNEAPOLIS , April 7, 2021 /PRNewswire/ -- VigiLanz , a clinical surveillance company, today announced the launch of three new event reporting solutions built on VigiLanz's award-winning enterprise software platform. The new solutions, VigiLanz Risk and Claims , VigiLanz Compliance , and VigiLanz Patient Relations , complement VigiLanz's existing Dynamic Safety Surveillance product to expand the platform's benefits and improve hospitals' bottom line by enabling them to quickly capture, monitor, and act on information, enhancing ... |
| 3/31/2021 |
Frost & Sullivan honours Wolters Kluwer's Sentri7 and POC Advisor clinical surveillance solutions with New Product Innovation Award |
knowledgespeak.com |
News / Frost & Sullivan honours Wolters Kluwer’s Sentri7 and POC Advisor clinical surveillance solutions with New Product Innovation Award Frost & Sullivan honours Wolters Kluwer’s Sentri7 and POC Advisor clinical surveillance solutions with New Product Innovation Award - March 31, 2021Clinical technology and evidence-based solutions provider Wolters Kluwer, Health , has been recognized by Frost & Sullivan with a 2021 New Product Innovation Award for its ‘state-of-the-art suite ... |
| 3/30/2021 |
Wolters Kluwer Clinical Surveillance Receives Frost & Sullivan New Product Innovation Award |
tmcnet.com |
Wolters Kluwer Clinical Surveillance Receives Frost & Sullivan New Product Innovation Award [March 30, 2021] Wolters Kluwer Clinical Surveillance Receives Frost & Sullivan New Product Innovation AwardWolters Kluwer, Health , a leading global provider of trusted clinical technology and evidence-based solutions, is recognized by Frost & Sullivan ( News - Alert ) with a 2021 New Product Innovation Award for its "state-of-the-art suite of clinical surveillance solutions that contribute to vastly improved ... |
| 3/30/2021 |
Wolters Kluwer Clinical Surveillance Receives Frost & Sullivan New Product Innovation Award |
financialbuzz.com |
Wolters Kluwer, Health , a leading global provider of trusted clinical technology and evidence-based solutions, is recognized by Frost & Sullivan with a 2021 New Product Innovation Award for its “state-of-the-art suite of clinical surveillance solutions that contribute to vastly improved patient outcomes and measurable reductions in the cost of care.”According to Victor Camlek, Principal Analyst for Frost & Sullivan’s global Healthcare & Life Sciences team, “Wolters ... |
| 3/28/2021 |
Apple Watch can keep an eye on the frailty of cardio individuals in your home - Technology Life |
technologylife.net |
March 27, 2021The Apple Watch on your wrist may act as an essential clinical surveillance device in the ideal conditions. According to MyHealth yApple and also MacRumors , Stanford scientists moneyed by Apple have figured out that the Apple Watch can precisely determine the frailty (or instead, the range took a trip in a six-minute stroll) of heart disease individuals while they go to house. Personal smartwatch usage was ... |
| 3/17/2021 |
PeraHealth and Caregility Partner to Deliver Seamless Integration of Video-Based Consults with Real-Time Predictive Analytics |
financialbuzz.com |
... with Caregility, a company dedicated to delivering care to wherever the patient is located through the use of the Caregility Virtual Care Platform . The Rothman Index enables at-risk patient identification through real-time clinical surveillance to support earlier detection of patient deterioration. Integration of the Caregility Virtual Care Platform with the Rothman Index solution allows care teams to launch virtual visits directly from the Rothman Index patient dashboard, building ... |
| 3/5/2021 |
GERD poses cancer risk |
cnpublications.net |
... and cancers of the larynx and esophagus. The study, which appears in the journal Cancer , adds to an existing body of evidence.The researchers hope that, if their results are confirmed, they might “inform clinical surveillance of GERD patients and suggest new avenues for prevention of these malignancies.”GERD is a type of chronic gastrointestinal disease that causes the contents of the stomach to rise into the esophagus.Researchers ... |
| 3/1/2021 |
A Gastroenterologist's Guide to Endoscopic Tattooing Methods |
gi-supply.com |
News and Events / A Gastroenterologist’s Guide to Endoscopic Tattooing Methods A Gastroenterologist’s Guide to Endoscopic Tattooing MethodsMARCH 1, 2021 There’s no doubt about the effectiveness of endoscopic tattoos as an integral tool for long-term clinical surveillance and surgical localization. Tattooing has proven to both decrease time spent in the operating room 1 and greatly improve tumor localization. 2 Not to mention, it’s also included ... |
| 2/23/2021 |
Acid reflux heightens risk for certain cancers, study finds |
Becker's Hospital Review |
... estimated that 17 percent of these cancers are attributable to GERD."GERD is a common gastrointestinal disorder, but future prospective studies are needed to replicate our findings," researchers said. "If replicated, they may inform clinical surveillance of GERD patients and suggest new avenues for prevention of these malignancies."To view the full findings, click here.More articles on oncology ... |
| 2/20/2021 |
Missouri begins clinical surveillance to monitor emerging COVID-19 variants |
ksdk.com |
Coronavirus Missouri begins clinical surveillance to monitor emerging COVID-19 variants Through its Coronavirus Sewershed Surveillance Project, the department found the COVID-19 UK variant in various locations throughout the state Author: Sasha Sander (KSDK) Published: 7:06 PM CST February 19, 2021 Updated: 7:06 PM CST February 19, 2021JEFFERSON CITY, Mo. — Although COVID-19 positivity rates continue to decline in Missouri, the Department of Health and Senior Services ... |
| 2/10/2021 |
We wiped out the flu this year. Could we do it again? |
MSN |
... been enough to virtually wipe out the flu this season.The Centers for Disease Control and Prevention (CDC) says that as of January 30, there have been just 1,316 positive flu cases in its clinical surveillance network since September. Around this time last year, it had logged 129,997 positive flu cases in the same time frame.Some of the drop may be because people aren’t going in and getting ... |
| 1/27/2021 |
Philips to acquire Capsule Technologies |
canhealth.com |
... 635 million (US). Capsule is a provider of medical device integration and data technologies for hospitals and healthcare organizations.Capsule’s Medical Device Information Platform – comprised of device integration, vital signs monitoring and clinical surveillance services – connects almost all existing medical devices and EMRs in hospitals through a vendor-neutral system, the companies said.Capsule’s platform captures streaming clinical data and transforms it into actionable information for ... |
| 1/21/2021 |
Philips Acquires Medical Device Integrator Capsule for $635M |
HIT Infrastructure |
... hospitals and healthcare organizations.Capsule’s Medical Device Information Platform connects almost all existing medical device EMRs in hospitals through a vendor-neutral system.The platform, comprised of device integration, vital signs monitoring, and clinical surveillance service, aims to enhance patient management, improve collaboration between care teams, and streamline workflows in the ICU. Dig Deeper Philips Innovates HIT Infrastructure with Phoenix Children’sThe acquisition of Capsule will enhance Royal ... |
| 1/20/2021 |
Philips Acquires Capsule Technologies |
axisimagingnews.com |
... agreement to acquire Capsule Technologies, Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations. Capsule’s Medical Device Information Platform—comprised of device integration, vital signs monitoring and clinical surveillance services—connects almost all existing medical devices and EMRs in hospitals through a vendor-neutral system.Moreover, Capsule’s platform captures streaming clinical data and transforms it into actionable information for patient care management ... |
| 1/19/2021 |
Philips to Acquire Capsule Technologies Inc. |
ortoday.com |
... to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations. Capsule’s Medical Device Information Platform – comprised of device integration, vital signs monitoring and clinical surveillance services – connects almost all existing medical devices and EMRs in hospitals through a vendor-neutral system. Capsule’s platform captures streaming clinical data and transforms it into actionable information for patient care management ... |
| 1/19/2021 |
Royal Philips buys connected med device company Capsule Technologies |
MobiHealthNews |
... Technologies for a whopping $635 million from Francisco Partners.Capsule is best known for its suite of connected medical devices and its data integration platform that can combine device integration, vital signs monitoring and clinical surveillance services. The tool was designed to link up medical devices and EHRs via a vendor neutral system.Over the years the company has also landed several FDA clearances. For example, the Capsule Vitals Plus ... |